Buyback yield (TTM)
N/A
Shareholder yield (TTM)
N/A
5Y share count change
18.5%
Buyback spend (TTM)
N/A
Cumulative buybacks
$30.36M
Key takeaways
- Diluted share count is up 18.5% over the last ~5 fiscal years — equity issuance and stock-based compensation are outpacing repurchases.
Dividend & buyback yield over time for Rocket Lab USA (RKLB)
Stacked annual yields — buyback yield (TTM cash repurchases ÷ market cap) plus dividend yield from the same fiscal-year-end key-metrics period — show how total cash return per dollar of equity has evolved.
Diluted vs basic shares (annual) for Rocket Lab USA (RKLB)
Diluted weighted-average shares are the EPS denominator — a falling count means buybacks are outpacing SBC dilution.
Year-over-year change in diluted shares for Rocket Lab USA (RKLB)
Green is fewer shares vs the prior fiscal year (net repurchase); red is growth (dilution). The earliest year shown has no prior year to compare.
Cash buyback spend over time for Rocket Lab USA (RKLB)
Latest: $0.00
Overview
The 2025 reading of Rocket Lab USA (RKLB) buyback spend is $0.00.
Rocket Lab USA buyback spend peaked at $30.36M in 2021; the latest annual figure is $0.00 in 2025 (100.0% below peak).
The record annual buyback spend stands at $30.36M, reached in 2021; the historical low of $0.00 was recorded in 2019.
Rocket Lab USA Buyback Spend 2025: $0.00
Rocket Lab USA buyback spend in 2025 was $0.00.
Rocket Lab USA Buyback Spend 2024: $0.00
Rocket Lab USA buyback spend in 2024 was $0.00.
Rocket Lab USA Buyback Spend 2023: $0.00
Rocket Lab USA buyback spend in 2023 was $0.00.
Rocket Lab USA Buyback Spend 2022: $0.00
Rocket Lab USA buyback spend in 2022 was $0.00, plunged 100.0% below 2021.
Rocket Lab USA Buyback Spend 2021: $30.36M
Rocket Lab USA buyback spend in 2021 was $30.36M.
See more financial history for Rocket Lab USA (RKLB).
Buyback, SBC & dilution history
Buyback spend, SBC, net dilution effect, and share count.
| 2025 | $0.00 | $71.10M | −$71.10M | — | 0.53B | +7.0% | |
| 2024 | $0.00 | $56.82M | −$56.82M | — | 0.50B | +2.9% | |
| 2023 | $0.00 | $53.46M | −$53.46M | — | 0.48B | +3.3% | |
| 2022 | $0.00 | $55.65M | −$55.65M | — | 0.47B | +3.1% | |
| 2021 | $30.36M | $32.56M | −$2.20M | 0.55% | 0.45B | +1.0% | |
| 2020 | $0.00 | $4.22M | −$4.22M | — | 0.45B | +11.7% | |
| 2019 | $0.00 | $3.93M | −$3.93M | — | 0.40B | — |
- 2025$0.00
- 2024$0.00
- 2023$0.00
- 2022$0.00
- 2021$30.36M
- 2020$0.00
- 2019$0.00
Buybacks vs stock-based compensation for Rocket Lab USA (RKLB)
Annual cash repurchases set against stock-based compensation. Coverage above 1× means buybacks fully offset the equity dilution from SBC. TTM coverage: 0.00×.
Buybacks vs dividends (share of cash returned) for Rocket Lab USA (RKLB)
How Rocket Lab USA splits cash returned to shareholders between dividends and buybacks.
Sector peers by buyback spend
Companies in the same sector as Rocket Lab USA, ranked by their latest buyback spend.
| $7.55B | |
| $5.19B | |
| $3.80B | |
| $2.68B | |
| $1.86B | |
| $1.14B | |
| $50.00M | |
| $0.00 |
- $7.55B
- $5.19B
- $2.68B
- $1.86B
- $1.14B
- $50.00M
- $0.00
Buyback capacity (TTM)
Free cash flow minus dividends paid versus actual TTM repurchases — the headroom bar shows how much of post-dividend FCF is still being deployed elsewhere.
Headroom $0.00 (TTM FCF − TTM dividends, clamped at zero).
Frequently asked questions
Data & methodology
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation